Third Harmonic Bio
targeting kit has been shown to broadly inhibit mast cell activity kit hin | Third Harmonic Bio
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
7 of 20
Similar slides by Third Harmonic Bio
See diffirences between slides (animation)
IPO
September 2022
targeting kit has been shown to broadly inhibit mast cell activity inhibition of kit drives both mast cell all patients | Third Harmonic Bio
Other recent decks by Third Harmonic Bio
See all presentations (2 decks)
IPO
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights